ELN

E559469

ELN was the stock ticker symbol for Elan Pharmaceuticals, an Irish biotechnology company known for developing treatments for neurological and autoimmune diseases.

All labels observed (1)

Label Occurrences
ELN canonical 4

How this entity was disambiguated

Statements (40)

Predicate Object
instanceOf analgesic drug
biotechnology company
monoclonal antibody drug
stock ticker symbol
acquiredBy Perrigo
acquisitionDate 2013
associatedCompany Elan Pharmaceuticals
collaboratedWith Biogen Idec
linked to: Biogen
country Ireland
countryOfIncorporation Ireland
developed Prialt
Tysabri
dissolved 2013
field Autoimmune diseases
Neurology
focus Alzheimer's disease research
neurodegenerative diseases
foundedBy American Home Products (spin-out origin context)
Donal Geaney
headquartersLocation Dublin, Ireland
linked to: Dublin
industry Biotechnology
Pharmaceuticals
listedOn Irish Stock Exchange
New York Stock Exchange
notableDrug Prialt
Tysabri
notableTechnology drug delivery technologies
represents Elan Pharmaceuticals
researchArea central nervous system disorders
immunology
specializesIn treatments for autoimmune diseases
treatments for neurological diseases
status defunct as independent company
stockExchange Irish Stock Exchange
New York Stock Exchange
stockTicker ELN
tradedAs ELN
treats Crohn's disease
multiple sclerosis
severe chronic pain

How these facts were elicited

Referenced by (4)

Full triples — surface form annotated when it differs from this entity's canonical label.

Elan Pharmaceuticals tradedAs ELN
subject linked to: ELN
Elan Pharmaceuticals stockTicker ELN
subject linked to: ELN